Abstract

Because enriched environment (EE) and exercise increase and aging decreases immune response, we hypothesized that environmental enrichment and aging will, respectively, delay and increase prion disease progression. Mice dorsal striatum received bilateral stereotaxic intracerebral injections of normal or ME7 prion infected mouse brain homogenates. After behavior analysis, animals were euthanized and their brains processed for astrocyte GFAP immunolabeling. Our analysis related to the environmental influence are limited to young adult mice, whereas age influence refers to aged mice raised on standard cages. Burrowing activity began to reduce in ME7-SE two weeks before ME7-EE, while no changes were apparent in ME7 aged mice (ME7-A). Object placement recognition was impaired in ME7-SE, NBH-A, and ME7-A but normal in all other groups. Object identity recognition was impaired in ME7-A. Cluster analysis revealed two morphological families of astrocytes in NBH-SE animals, three in NBH-A and ME7-A, and four in NBH-EE, ME7-SE, and ME7-EE. As compared with control groups, astrocytes from DG and CA3 prion-diseased animals show significant numerical and morphological differences and environmental enrichment did not reverse these changes but induced different morphological changes in GFAP+ hippocampal astroglia. We suggest that environmental enrichment and aging delayed hippocampal-dependent behavioral and neuropathological signs of disease progression.

Highlights

  • Prion diseases are fatal neurodegenerative diseases characterized by accumulation of prion misfolded (PrPsc) protein, gliosis, synaptic dysfunction, and, at late stages, neuronal loss [1,2,3,4,5]

  • We evaluated possible correlations between behavioral changes related to prion disease progression and number and morphology of astrocytes in both young adult and aged prion-diseased mice

  • Our findings related to the environmental influence on prion disease progression are limited to young mice whereas those related to age influence are limited to mice raised on standard cages

Read more

Summary

Introduction

Prion diseases are fatal neurodegenerative diseases characterized by accumulation of prion misfolded (PrPsc) protein, gliosis, synaptic dysfunction, and, at late stages, neuronal loss [1,2,3,4,5]. This sequence of events shares the neuropathological features of chronic neurodegeneration in Alzheimer’s disease (AD) and is well reproduced in the ME7 murine young adult model of prion disease [6,7,8]. A close relationship between PrPSc and enhanced glial fibrillary acidic protein (GFAP) immunoreactivity at different stages of the disease has been identified [3, 12], giving morphological evidence of specific

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call